daily equity-report by epic research 9 jan 2013

4
HEADLINES Indian Market Indian equity markets up by 0.22% Nifty up by 13.30 pts and settle at 6001.70 Sensex up by 51.10 pts at 19742.52 Bank Nifty up by 16.80 pts at 12725.50 Global Market European markets were up with FTSE up by 6.93 closed at 6071,CAC up by 14.52 closed at 3719 and DAX down by 5.16 closed at 7727. Dow future was down 10.00 closed at 13297.00 WWW.EPICRESEARCH.CO 09752199966 DAILY EQUITY NEWSLETTER 9 TH JANUARY 2013 HEADLINES Fitch renews warning on India's outlook; rupee falls MOIL plans to up production, invest Rs 1,200 cr in phases Biocon gets DCGI approval to market anti-psoriasis drug 25 bps rate cut won't push bonds further: HDFC Bank

Upload: epic-daily-report

Post on 22-Nov-2014

376 views

Category:

Documents


0 download

DESCRIPTION

Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.

TRANSCRIPT

Page 1: Daily equity-report by epic research 9 jan 2013

-=6 HEADLINES

Indian Market

Indian equity markets up by 0.22%

Nifty up by 13.30 pts and settle at 6001.70

Sensex up by 51.10 pts at 19742.52

Bank Nifty up by 16.80 pts at 12725.50

Global Market

European markets were up with FTSE up by 6.93 closed at 6071,CAC up by 14.52 closed at 3719 and DAX down by 5.16 closed at 7727.

Dow future was down 10.00 closed at

13297.00

WWW.EPICRESEARCH.CO 09752199966

DAILY EQUITY NEWSLETTER

9TH JANUARY 2013

HEADLINES

• Fitch renews warning on India's outlook;

rupee falls

• MOIL plans to up production, invest Rs

1,200 cr in phases

• Biocon gets DCGI approval to market

anti-psoriasis drug

• 25 bps rate cut won't push bonds further:

HDFC Bank

Page 2: Daily equity-report by epic research 9 jan 2013

FII’s and DII’s

CATEGORY DATE BUY SELL NET

FII 8-Jan-13 3177.07 2289.69 887.38

DII 8-Jan-13 735.4 1763.52 -1028.12

NIFTY DAILY PIVOTS

PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4

NIFTY 6119 6076 6033 6017 5990 5974 5947 5904 5861

WWW.EPICRESEARCH.CO 09752199966

MARKET ANALYSIS:

Key benchmark indices edged higher after Prime Minister Dr. Manmohan Singh said that despite

domestic constraints and challenges, India is confident that the strong economic fundamentals, backed

by sound policies, will enable the country to return to a higher growth path. Gains in European stocks

also supported domestic bourses.

The BSE Sensex was up 55.06 points or 0.28% to 19,746.48.

S&P CNX Nifty was up 14.45 points or 0.24% to 6,002.85.

Among the 30-share Sensex pack, 16 rose while the rest of them fell.

FMCG stocks gained on renewed buying. Godrej Consumer Products, Tata Global Beverages,

Hindustan Unilever, Dabur India and Nestle India gained by 0.04% to 1.02%. Pharma stocks edged

higher on renewed buying. Sun Pharmaceutical Industries rose 1.28%.Cipla gained 1.58% to Rs 430.

The stock hit record high of Rs 431.70 in intraday trade today, 8 January 2013.Dr Reddy's Laboratories

rose 1.05% to Rs 1,906.50. The stock hit record high of Rs 1,919.25 in intraday trade today, 8 January

2013. racle Financial Services Software jumped 3.18% to Rs 3376.65. The stock hit record high of Rs

3395 in intraday trade today, 8 January 2013.

STOCKS TO WATCH

TATA STEEL

LT

PETRONET

ONGC

SCRIPS IN BAN PERIOD

SUZLON

KTKBANK

RENUKA

IFCI

Page 3: Daily equity-report by epic research 9 jan 2013

09752199966

.

EXPERT OPINION

NIFTY

Nifty looks Consolidate

Strategy: Sell on rise

Support: 5960

Resistance: 6050

BANK NIFTY

Bank Nifty looks Consolidate

Strategy: Sell on rise

Support: 12650

Resistance: 12800

.0

GAINERS AND LOOSERS

PREVIOUS PERFORMANCE

TYPE SCRIP B/S RESULT

CASH HINDUSTAN PETROLEUM

B SL TRIGERRED

CASH ITC S NOT

EXECUTED

FUTURE HCL S SL TRIGERRED

FUTURE ADANI POWER

B NOT

EXECUTED

UPCOMING RESULTS

GUJ NRE COKE

INDUSIND BANK

KITEX GARMENTS

YASH MANAGE

DAILY NIFTY GAINERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHANG

E

Reliance

Infra 567.10 2738.98 550.95 16.15 2.93

ITC 285.70 8956.38 279.05 6.65 2.38

HDFC 840.30 1812.48 822.95 17.35 2.11

Power Grid

116.45 4020.41 114.40 2.05 1.79

BHEL 243.90 2987.66 239.80 4.10 1.71

DAILY NIFTY LOOSERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHAN

GE

IDFC 180.40 4857.41 183.90 -3.50 -1.90

Tata Steel

433.35 3776.39 440.90 -7.55 -1.71

Wipro 398.15 1094.73 404.95 -6.80 -1.68

Sesa Goa 199.70 1443.32 202.65 -2.95 -1.46

Larsen & Toubro

1566.90 2653.80 1588.15 -21.25 -1.34

Page 4: Daily equity-report by epic research 9 jan 2013

.

MARKET CALLS

CASH

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

PETRONET BUY 167.20 168.20 169.70 166.20

LARSEN TOURBO SELL 1565.00 1561.00 1555.00 1569.00

FUTURE

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

TATA STEEL SELL 436.00 432.00 426.00 440.00

ONGC BUY 293.00 295.00 298.00 291.00

Disclaimer

The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.

All Rights Reserved. Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.